Moleculin Biotech reports warrant exercise for $2.7M; shares outstanding rise to 7.07M

Moleculin Biotech, Inc.

Warrants to purchase 1,361,500 shares exercised, generating gross proceeds of ~$2.7 million.
As of June 29, 2026, common shares outstanding total 7,065,000.
Corporate presentation posted on company website; no material updates disclosed in filing.

item 7.01 item 8.01 item 9.01

Moleculin Biotech, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-26-022087

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.